NDC 83027-0026 Pancreas Liquescence

Cinnamomum,Gymnema Sylvestre,Phosphoricum Acidum,Syzygium Jambolanum,Trigonella - View Dosage, Usage, Ingredients, Routes, UNII

Product Information

NDC Product Code:
83027-0026
Proprietary Name:
Pancreas Liquescence
Non-Proprietary Name: [1]
Cinnamomum, Gymnema Sylvestre, Phosphoricum Acidum, Syzygium Jambolanum, Trigonella Foenum-graceum, Argentum Nitricum, Chionanthus Virginica, Hepar Suis, Pancreas Suis, Rhus Aromatica, Sulphur, Lycopodium Clavatum, Chromium Picolinate, Chromium Metallicum, Phosphorus, Vanadium Metallicum, Zincum Metallicum, Murex Purpurea, Dna, Insulinum (human), Uranium Nitricum
Substance Name: [2]
Chionanthus Virginicus Root Bark; Chromium; Chromium Picolinate; Cinnamon; Fenugreek Seed; Gymnema Sylvestre Leaf; Herring Sperm Dna; Hexaplex Trunculus Hypobranchial Gland Juice; Insulin Human; Lycopodium Clavatum Spore; Phosphoric Acid; Phosphorus; Pork Liver; Rhus Aromatica Root Bark; Silver Nitrate; Sulfur; Sus Scrofa Pancreas; Syzygium Cumini Seed; Uranyl Nitrate Hexahydrate; Vanadium; Zinc
NDC Directory Status:
Human Otc Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route(s): [4]
  • Oral - Administration to or by way of the mouth.
  • Labeler Name: [5]
    Nutritional Specialties, Inc.
    Labeler Code:
    83027
    Marketing Category: [8]
    UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
    Start Marketing Date: [9]
    03-27-2023
    Listing Expiration Date: [11]
    12-31-2024
    Exclude Flag: [12]
    N
    Code Structure:
    Code Navigator:

    Product Packages

    NDC Code 83027-0026-1

    Package Description: 120 mL in 1 BOTTLE, GLASS

    Product Details

    What is NDC 83027-0026?

    The NDC code 83027-0026 is assigned by the FDA to the product Pancreas Liquescence which is a human over the counter drug product labeled by Nutritional Specialties, Inc.. The generic name of Pancreas Liquescence is cinnamomum, gymnema sylvestre, phosphoricum acidum, syzygium jambolanum, trigonella foenum-graceum, argentum nitricum, chionanthus virginica, hepar suis, pancreas suis, rhus aromatica, sulphur, lycopodium clavatum, chromium picolinate, chromium metallicum, phosphorus, vanadium metallicum, zincum metallicum, murex purpurea, dna, insulinum (human), uranium nitricum. The product's dosage form is liquid and is administered via oral form. The product is distributed in a single package with assigned NDC code 83027-0026-1 120 ml in 1 bottle, glass . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

    What are the uses for Pancreas Liquescence?

    Adults 1 to 2 teaspoons one to two times daily. Children under twelve one half adult dosage. Consult a physician for use in children under 12 years of age.

    What are Pancreas Liquescence Active Ingredients?

    An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    Which are Pancreas Liquescence UNII Codes?

    The UNII codes for the active ingredients in this product are:

    Which are Pancreas Liquescence Inactive Ingredients UNII Codes?

    The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

    Which are the Pharmacologic Classes for Pancreas Liquescence?

    * Please review the disclaimer below.

    Product Footnotes

    [1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

    [2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

    [3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

    [4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

    [5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

    [8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

    [9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

    [11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

    [12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".